BEACOPP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: BEACOPP; BEACOPP Regimen; BEACOPP regimen; Bleomycin-Etoposide-Adriamycin-Cyclophosphamide-Oncovin-Procarbazine-Prednisone Regimen; Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Procarbazine/Vincristine

Overview

BEACOPP regimen refers to an a chemotherapy regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone, used for the treatment of advanced-stage Hodgkin lymphoma.^[1]^[2]

Regimen

BBleomycin

EEtoposide

ADoxorubicin (Adriamycin)

CCyclophosphamide

OVincristine (Oncovin)

PProcarbazine

PPrednisone

Indications

Advanced-stage Hodgkin lymphoma ^[3]

References

↑ “NCI Thesaurus”.
↑ “R-CHOP – National Cancer Institute”.
↑ Cheson BD (2014). “Which Hodgkin’s patients in the Unites States should be treated with BEACOPP?”. Curr Hematol Malig Rep. 9 (3): 222–6. doi:10.1007/s11899-014-0213-6. PMID 24879421.

[1] “NCI Thesaurus”.

[2] “R-CHOP – National Cancer Institute”.

[pmid24879421-3] Cheson BD (2014). “Which Hodgkin’s patients in the Unites States should be treated with BEACOPP?”. Curr Hematol Malig Rep. 9 (3): 222–6. doi:10.1007/s11899-014-0213-6. PMID 24879421.

[1]

[2]

[3]